J McVernon

Summary

Affiliation: University of Melbourne
Country: Australia

Publications

  1. doi request reprint Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study
    Jodie McVernon
    Vaccine and Immunisation Research Group, Murdoch Children s Research Institute and Melbourne School of Population Health, The University of Melbourne, Parkville, Australia
    Influenza Other Respir Viruses 5:7-11. 2011
  2. doi request reprint Panvax(®): a monovalent inactivated unadjuvanted vaccine against pandemic influenza A (H1N1) 2009
    Jodie McVernon
    Vaccine and Immunisation Research Group, Murdoch Childrens Research Institute and Melbourne School of Population Health, The University of Melbourne, Parkville, Victoria 3010, Australia
    Expert Rev Vaccines 10:35-43. 2011
  3. pmc Household transmission of respiratory viruses - assessment of viral, individual and household characteristics in a population study of healthy Australian adults
    James M McCaw
    Murdoch Children s Research Institute and Melbourne School of Population Health, The University of Melbourne, Parkville, Victoria, 3010, Australia
    BMC Infect Dis 12:345. 2012
  4. pmc Leave entitlements, time off work and the household financial impacts of quarantine compliance during an H1N1 outbreak
    Anne M Kavanagh
    Centre for Women s Health, Gender and Society, Melbourne School of Population Health, The University of Melbourne, Melbourne, Victoria, Australia
    BMC Infect Dis 12:311. 2012
  5. doi request reprint Modelling strategic use of the national antiviral stockpile during the CONTAIN and SUSTAIN phases of an Australian pandemic influenza response
    Jodie McVernon
    Murdoch Childrens Research Institute and Melbourne School of Population Health, University of Melbourne, Victoria, Australia
    Aust N Z J Public Health 34:113-9. 2010
  6. doi request reprint A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers
    Jodie McVernon
    Murdoch Children s Research Institute and Melbourne School of Population Health, The University of Melbourne, Melbourne, Australia
    Pediatr Infect Dis J 31:e15-23. 2012
  7. pmc Sources, perceived usefulness and understanding of information disseminated to families who entered home quarantine during the H1N1 pandemic in Victoria, Australia: a cross-sectional study
    Anne M Kavanagh
    Centre for Women s Health, Gender and Society, Melbourne School of Population Health, The University of Melbourne, Melbourne, Victoria, Australia
    BMC Infect Dis 11:2. 2011
  8. pmc Recommendations for and compliance with social restrictions during implementation of school closures in the early phase of the influenza A (H1N1) 2009 outbreak in Melbourne, Australia
    Jodie McVernon
    Vaccine and Immunisation Research Group, Murdoch Children s Research Institute and Melbourne School of Population Health, University of Melbourne, Australia
    BMC Infect Dis 11:257. 2011
  9. doi request reprint Model answers or trivial pursuits? The role of mathematical models in influenza pandemic preparedness planning
    J McVernon
    Vaccine and Immunisation Research Group, Murdoch Childrens Research Institute and School of Population Health, University of Melbourne, Carlton, Vic, Australia
    Influenza Other Respir Viruses 1:43-54. 2007
  10. ncbi request reprint Host and environmental factors associated with Hib in England, 1998-2002
    J McVernon
    Immunisation Department, Health Protection Agency Centre for Infections, London, UK
    Arch Dis Child 93:670-5. 2008

Detail Information

Publications27

  1. doi request reprint Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study
    Jodie McVernon
    Vaccine and Immunisation Research Group, Murdoch Children s Research Institute and Melbourne School of Population Health, The University of Melbourne, Parkville, Australia
    Influenza Other Respir Viruses 5:7-11. 2011
    ..Seroprevalence studies conducted on stored serum collections indicated low levels of antibody to the novel strain in this age group, leading many to recommend priority immunisation of paediatric populations...
  2. doi request reprint Panvax(®): a monovalent inactivated unadjuvanted vaccine against pandemic influenza A (H1N1) 2009
    Jodie McVernon
    Vaccine and Immunisation Research Group, Murdoch Childrens Research Institute and Melbourne School of Population Health, The University of Melbourne, Parkville, Victoria 3010, Australia
    Expert Rev Vaccines 10:35-43. 2011
    ..This facilitated early licensure and then rapid rollout for population immunization from October 2009. The vaccine's safety profile in the Australian population has been excellent...
  3. pmc Household transmission of respiratory viruses - assessment of viral, individual and household characteristics in a population study of healthy Australian adults
    James M McCaw
    Murdoch Children s Research Institute and Melbourne School of Population Health, The University of Melbourne, Parkville, Victoria, 3010, Australia
    BMC Infect Dis 12:345. 2012
    ..Household transmission of influenza-like illness (ILI) may vary with viral and demographic characteristics. We examined the effect of these factors in a population-based sample of adults with ILI...
  4. pmc Leave entitlements, time off work and the household financial impacts of quarantine compliance during an H1N1 outbreak
    Anne M Kavanagh
    Centre for Women s Health, Gender and Society, Melbourne School of Population Health, The University of Melbourne, Melbourne, Victoria, Australia
    BMC Infect Dis 12:311. 2012
    ....
  5. doi request reprint Modelling strategic use of the national antiviral stockpile during the CONTAIN and SUSTAIN phases of an Australian pandemic influenza response
    Jodie McVernon
    Murdoch Childrens Research Institute and Melbourne School of Population Health, University of Melbourne, Victoria, Australia
    Aust N Z J Public Health 34:113-9. 2010
    ..To define optimum use of the national antiviral stockpile during the early phases of the response to pandemic influenza in Australia, to inform the 2008 revision of the Australian Health Management Plan for Pandemic Influenza...
  6. doi request reprint A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers
    Jodie McVernon
    Murdoch Children s Research Institute and Melbourne School of Population Health, The University of Melbourne, Melbourne, Australia
    Pediatr Infect Dis J 31:e15-23. 2012
    ..Recent shifts in serogroup dominance in some settings highlight the desirability of polysaccharide-conjugate vaccines with broader meningococcal coverage than serogroup C vaccines in widespread use...
  7. pmc Sources, perceived usefulness and understanding of information disseminated to families who entered home quarantine during the H1N1 pandemic in Victoria, Australia: a cross-sectional study
    Anne M Kavanagh
    Centre for Women s Health, Gender and Society, Melbourne School of Population Health, The University of Melbourne, Melbourne, Victoria, Australia
    BMC Infect Dis 11:2. 2011
    ..Specifically, we outline their sources of information; the perceived usefulness of each source; and associations between understanding of recommendations and compliance...
  8. pmc Recommendations for and compliance with social restrictions during implementation of school closures in the early phase of the influenza A (H1N1) 2009 outbreak in Melbourne, Australia
    Jodie McVernon
    Vaccine and Immunisation Research Group, Murdoch Children s Research Institute and Melbourne School of Population Health, University of Melbourne, Australia
    BMC Infect Dis 11:257. 2011
    ..Oseltamivir (Tamiflu) was available for treatment or prophylaxis...
  9. doi request reprint Model answers or trivial pursuits? The role of mathematical models in influenza pandemic preparedness planning
    J McVernon
    Vaccine and Immunisation Research Group, Murdoch Childrens Research Institute and School of Population Health, University of Melbourne, Carlton, Vic, Australia
    Influenza Other Respir Viruses 1:43-54. 2007
    ..To this end, we encourage researchers to access FluWeb, an on-line influenza database of historical pandemics and outbreaks...
  10. ncbi request reprint Host and environmental factors associated with Hib in England, 1998-2002
    J McVernon
    Immunisation Department, Health Protection Agency Centre for Infections, London, UK
    Arch Dis Child 93:670-5. 2008
    ..Declining effectiveness of the UK's Hib vaccine programme was observed between 1998 and 2002...
  11. pmc Understanding the impact of Hib conjugate vaccine on transmission, immunity and disease in the United Kingdom
    J McVernon
    Population Biology of Infectious Disease Group, Department of Zoology, University of Oxford, UK
    Epidemiol Infect 136:800-12. 2008
    ..The contribution of herd immunity to disease control was reinforced. Possible intervention strategies will be explored in subsequent work...
  12. pmc Changes in the epidemiology of epiglottitis following introduction of Haemophilus influenzae type b (Hib) conjugate vaccines in England: a comparison of two data sources
    J McVernon
    Immunisation Department, Health Protection Agency Centre for Infections, Colindale, London, UK
    Epidemiol Infect 134:570-2. 2006
    ..The need for a high index of suspicion to allow early diagnosis of this life-threatening clinical presentation is reinforced...
  13. pmc Diagnosis and antiviral intervention strategies for mitigating an influenza epidemic
    Robert Moss
    Vaccine and Immunisation Research Group, Murdoch Childrens Research Institute and Melbourne School of Population Health, The University of Melbourne, Parkville, Australia
    PLoS ONE 6:e14505. 2011
    ..Here we identify optimal delivery strategies for antiviral interventions accounting for logistical constraints, and so determine how to improve a strategy's impact...
  14. doi request reprint Understanding mortality in the 1918-1919 influenza pandemic in England and Wales
    Dora C Pearce
    Vaccine and Immunisation Research Group, Melbourne School of Population Health, The University of Melbourne, Parkville, Vic, Australia
    Influenza Other Respir Viruses 5:89-98. 2011
    ..The causes of recurrent waves in the 1918-1919 influenza pandemic are not fully understood...
  15. doi request reprint Immunogenicity and safety of an investigational combined haemophilus influenzae type B-Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine
    Terry Nolan
    Vaccine and Immunisation Research Group, Murdoch Children s Research Institute and School of Population Health, University of Melbourne, Victoria, Australia
    Pediatr Infect Dis J 30:190-6. 2011
    ..Neisseria meningitidis serogroups B, C, and Y cause most meningococcal disease in industrialized countries. A Haemophilus influenzae type b-meningococcal serogroups C and Y-tetanus toxoid conjugate vaccine (HibMenCY-TT) was evaluated...
  16. pmc Comparison of three methods for ascertainment of contact information relevant to respiratory pathogen transmission in encounter networks
    James M McCaw
    Murdoch Childrens Research Institute, University of Melbourne, Parkville, Vic, Australia
    BMC Infect Dis 10:166. 2010
    ..We report on a pilot study designed to assess three different methods (one retrospective, two prospective) for obtaining contact data relevant to the determination of these mixing patterns...
  17. ncbi request reprint Prophylaxis or treatment? Optimal use of an antiviral stockpile during an influenza pandemic
    James M McCaw
    Vaccine and Immunisation Research Group, School of Population Health, The University of Melbourne, VIC 3010, Australia
    Math Biosci 209:336-60. 2007
    ..In contrast, a treatment based strategy typically does not delay the onset of a pandemic by an appreciable amount and, in general, is not capable of significantly reducing the attack rate from baseline...
  18. pmc Impact of emerging antiviral drug resistance on influenza containment and spread: influence of subclinical infection and strategic use of a stockpile containing one or two drugs
    James M McCaw
    Vaccine and Immunisation Research Group, Murdoch Childrens Research Institute and Melbourne School of Population Health, The University of Melbourne, Parkville, Victoria, Australia
    PLoS ONE 3:e2362. 2008
    ..We explored factors promoting resistance within a dynamic infection model, and considered ways in which one or two drugs might be distributed to delay the spread of resistant strains or mitigate their impact...
  19. doi request reprint Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children
    Terry Nolan
    Melbourne School of Population Health, The University of Melbourne, Victoria, Australia
    Vaccine 26:6383-91. 2008
    ....
  20. doi request reprint Safety and immunogenicity of an inactivated thimerosal-free influenza vaccine in infants and children
    Terry Nolan
    Vaccine and Immunisation Research Group at the Murdoch Children s Research Institute and the Melbourne School of Population Health, University of Melbourne, Victoria 3010, Australia
    Influenza Other Respir Viruses 3:315-25. 2009
    ..Our objective was to evaluate the safety, reactogenicity and immunogenicity of a thimerosal-free inactivated influenza vaccine (Fluvax; CSL Limited, Parkville, Australia) in children aged 6 months to <9 years...
  21. doi request reprint Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial
    Terry Nolan
    Vaccine and Immunization Research Group, School of Population Health, University of Melbourne, and Murdoch Children s Research Institute, Victoria, Australia
    JAMA 303:37-46. 2010
    ..In the ongoing influenza pandemic, a safe and effective vaccine against 2009 influenza A(H1N1) is needed for infants and children...
  22. pmc Prior immunity helps to explain wave-like behaviour of pandemic influenza in 1918-9
    John D Mathews
    Vaccine and Immunisation Research Group, Melbourne School of Population Health, University of Melbourne, 3010, Victoria, Australia
    BMC Infect Dis 10:128. 2010
    ..Were they unexposed, or protected by pre-existing cross-immunity in the first wave, by acquired immunity in later waves, or were their infections asymptomatic?..
  23. pmc Understanding Australia's influenza pandemic policy on the strategic use of the antiviral drug stockpile
    James M McCaw
    Vaccine and Immunisation Research Group, Melbourne School of Population Health, University of Melbourne and Murdoch Childrens Research Institute, Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Vic, Australia
    Med J Aust 191:136-7. 2009
    ..Targeted post-exposure prophylaxis represents a more efficient use of the stockpile than treatment alone...
  24. doi request reprint Pandemic controllability: a concept to guide a proportionate and flexible operational response to future influenza pandemics
    J M McCaw
    Melbourne School of Population Health, The University of Melbourne, Melbourne, Australia
    J Public Health (Oxf) 36:5-12. 2014
    ..By introducing a pragmatic framework for relating the assessment of impact to the ability to mitigate an epidemic (controllability), we hope to address a present omission identified in pandemic response plans. ..
  25. pmc Likely effectiveness of pharmaceutical and non-pharmaceutical interventions for mitigating influenza virus transmission in Mongolia
    K J Bolton
    Melbourne School of Population Health, University of Melbourne, Carlton, Victoria 3010, Australia
    Bull World Health Organ 90:264-71. 2012
    ..To assess the likely benefit of the interventions under consideration for use in Mongolia during future influenza pandemics...
  26. doi request reprint Understanding influenza transmission, immunity and pandemic threats
    John D Mathews
    Melbourne School of Population Health, The University of Melbourne, Melbourne, Australia
    Influenza Other Respir Viruses 3:143-9. 2009
    ..Nevertheless, partial protection, even of short duration, induced by prior seasonal influenza or vaccination against it, could provide important protection in the early stages of a new pandemic...
  27. pmc A biological model for influenza transmission: pandemic planning implications of asymptomatic infection and immunity
    John D Mathews
    Vaccine and Immunisation Research Group, Murdoch Childrens Research Institute and School of Population Health, The University of Melbourne, Parkville, Victoria, Australia
    PLoS ONE 2:e1220. 2007
    ..We have modelled multiple wave outbreaks of influenza from different populations to allow for changing immunity and asymptomatic infection and to make inferences about R(0)...